Gain Therapeutics, Inc. (GANX) Common Stock, Shares, Outstanding 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Gain Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from 2020 to 2024.
  • Gain Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 18 M shares, a 49.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 18 M +5.95 M +49.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 16.2 M +4.32 M +36.4% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 12.8 M +899 K +7.57% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 12.6 M +749 K +6.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 12.1 M +204 K +1.72% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 11.9 M 0 0% Dec 31, 2022 10-K 2024-03-26
Q3 2022 11.9 M +3.63 K +0.03% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 11.9 M +6.91 K +0.06% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 11.9 M +6.91 K +0.06% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 11.9 M +8.34 M +235% Dec 31, 2021 10-K 2023-03-23
Q3 2021 11.9 M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 11.9 M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 11.9 M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 3.54 M Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.